Cannible — Cannabis, explained.

Cannabis education, buying guides, and news — plain-English and ungated.

• 20% Terpenes or 70% THC? Live Rosin vs Live Resin for Seasoned Buyers — 20% Terpenes or 70% THC? Live Rosin vs Live Resin for Seasoned Buyers !
• Trump Commutes Two Federal Marijuana Sentences — President Trump commuted two federal marijuana sentences on September 4, 2026. Here is what clemency actually changes, and why rescheduling would not have done the same job.
• Maryland vs. "Terps": What a University's Cease-and-Desist Reveals About Cannabis Branding Risk — The University of Maryland told a Colorado terpene company to drop its name, its logo, and a federal trademark. The company said no. Here is what is actually at stake.
• The Old Farmer's Almanac Now Treats Cannabis Like Tomatoes, and That Tells You Something — The Almanac has been printing since 1792. It now covers cannabis the same way it covers peppers and cucumbers. That ordinariness is the story.
• Method Man Extends TICAL Into Cannabis Accessories With the Weedgets Maze-X — TICAL Official and Weedgets have co-released a limited-edition Maze-X pipe. The hardware is Weedgets. The 30 years of cultural weight is Method Man's.
• How Calvin Johnson Turned an NFL Pain Story Into a Cannabis Company — Calvin Johnson and Rob Sims co-founded Primitiv after retiring from the NFL. In 2026 the company refocused on premium Michigan cultivation. Here is what is documented, and what is still testimony.
• Nebraska Supreme Court Upholds the State's Medical Cannabis Laws — Nebraska's Supreme Court upheld both 2024 medical cannabis measures in a unanimous ruling. The legal threat is gone, but dispensaries are not open yet.
• Cannabis Edibles Can Impair Driving Even When Blood THC Looks Low — A randomized trial found edible THC impaired simulated driving at doses that left blood THC below most legal thresholds. Feeling fine and testing clean are both unreliable signals.
• A Worker Died at a California Cannabis Farm. The Chemical Question Now Hangs Over Every Grow. — Yufang Lan died on August 27 after being hospitalized unresponsive. Investigators searched the Lower Lake cultivation site over possible hazardous chemical use, and the cause of death is still unconfirmed.
• A Journalist Sues Eleven Federal Agencies for Records From the Glass House Farms Raid — Eleven federal agencies refused to release records from the July 10, 2025 Glass House Farms raid. A journalist is now suing all of them at once.
• New York's Licensed Cannabis Cultivation Capacity Reaches 12 Million Square Feet — New York's licensed adult-use cultivation canopy jumped from 9.1 million to 12 million square feet between March and August 2025. Actual production tells a quieter story.
• San Diego County Opens Unincorporated Areas to Cannabis Business — San Diego County supervisors voted 3-2 to allow regulated cannabis businesses on unincorporated land. The policy takes effect in 30 days, but nobody opens without county and state approval.
• A THC Spirit That Turns Its Empty Bottle Into a Bong — A 750 mL THC bottle built to sit next to the whiskey, with hardware that turns the empty into a bong. The format is the product.
• Jersey's Medical Cannabis Prescriptions Jumped 35% in One Year — Jersey's medical cannabis dispensing grew 35% in a single year while broader reform stalled at the drafting stage. Here is what the numbers actually measure.
• Medical Cannabis Laws and a 6.9% Drop in Sick Days: What the Data Actually Says — Researchers ran 35 years of federal survey data against a long-held assumption about cannabis and workforce attendance. The assumption did not hold up.
• The 25th Guilty Plea Ends a Cannabis Network That Shipped More Than 15,000 Pounds — Twenty-five defendants, one Fresno-to-Albany pipeline, more than 15,000 pounds. The prosecution is finished. The economics behind it are not.
• A Deadly Warehouse Robbery Shows What Unlicensed Cannabis Inventory Really Costs — An unlicensed Mount Vernon warehouse held 1,600 pounds of marijuana and no way to call the police. Two people died in the robbery that followed.
• Cannabis Permits Became Currency in a Southern California Corruption Network — Buried backyard cash got the headlines. The real story is a permitting system that turned government approval into a tradable asset.
• Colorado Legalized Cannabis Years Ago but the Pardons Have Yet to Materialize — Colorado voters legalized cannabis in 2012. In 2026 the governor is still issuing pardons for possession, including one man who waited 21 years. Here is why the law changing did not change the records.
• Canada Is Nearly Matching California in Legal Cannabis Sales. One Word Explains Why. — Canada posted a record C$517.8 million in licensed cannabis sales in June 2026, closing on California with a similar population. The difference is how many stores people can actually reach.
• Cannabis Smoking Ties Its Record High While Cigarettes Sit at Their Record Low — More U.S. adults smoke cannabis than smoke cigarettes. Here is what the July 2026 Gallup reading actually measured, and the questions it cannot answer.
• How Christopher Hinson Built Hazy Harvest, a Black Family-Owned Cannabis Dispensary
• THCA vs Delta 9: The Chemical Difference That Explains Everything
• In Maryland, diversity in cannabis ownership is increasing, but not in the way people think.
• Who Shouldn't Use Cannabis — Most cannabis-safety writing describes effects. The more useful question is narrower: is there a reason you specifically shouldn't — and who decided that?
• The Entourage Effect Grew Up: What Five Years of Receptor Studies Actually Measured — For years the entourage effect was an argument, not a finding. A run of receptor studies has changed that — but the evidence is narrower, and more contested, than the slogan suggests.
• California State Regulatory Movement: What Changed, What's Coming, What Reaches Californians — Montana's recall rule is already in force. Oregon's edible cap is a bill nobody has filed yet. Telling those two apart is most of the job.
• A Drug Made From Marijuana Is Not Marijuana — The study was real, the drug was real, and the result was modest. What did not survive the trip from the journal to the counter is the part that matters: what was actually in the bottle.
• Legal to Buy, Fireable to Use — California's own legislature wrote it into statute: the metabolites a standard cannabis test looks for do not indicate impairment. Here is what that means for your job — and where it doesn't apply.
• Nevada's Cannabis Sales Fell 8.6%. Its Bright Spot Has Two Locations. — Nevada's regulated cannabis market shrank again. Consumption lounges are the state's answer. The math on whether that works is worth doing.
• Massachusetts Wants $7.9 Million Before It Opens Cannabis Cafés — Massachusetts wrote its consumption-lounge rules months ago. The budget request tells you when they might actually happen.
• A Judge Let Texas's THC Ban Stand. The Real Fight Hasn't Happened Yet. — Texas's ban on hemp-derived THC survived its first courtroom test — but a denied restraining order isn't a ruling on the merits, and the case is still live.
• A Cannabis Trial in Severe Dementia Missed Its Main Target. Read Past the Headline. — The headlines say a cannabis trial in severe dementia worked. The trial's own primary outcome says otherwise. Both things are true, and the distinction matters.
• California Just Sent a Cannabis Packaging Bill to the Governor. Operators Have Until 2028. — AB 2249 cleared its final legislative hurdle 69–1 and is headed to the governor. If signed, it rewrites what California cannabis packaging may look like — with a long runway.
• Minnesota's Central Hub Gets New Licensed Dispensary: What Trailhead's Brainerd Opening Means for Adult-Use Access — Trailhead Cannabis Company has opened a licensed dispensary in Brainerd at 17951 Highway 371, bringing regulated adult-use retail to central Minnesota. The family-owned operation, open daily from 10 AM to 9 PM, represents the ongoing expansion of Minnesota's legal cannabis market following adult-use legalization.
• HHC vs. Delta 8: What You Need to Know Before You Buy — HHC vs. Delta 8: What You Need to Know Before You Buy !
• Is Weed Legal in Florida? What Residents and Visitors Need to Know — Is Weed Legal in Florida? What Residents and Visitors Need to Know !
• Indica vs Sativa: What to Check Before You Buy — Indica vs Sativa: What to Check Before You Buy ! Hands comparing cannabis indica and sativa buds The short answer: indica vs sativa labels are not reliable predictors of how a product will make you feel.
• How Long Do Edibles Last: What to Expect and How to Plan — How Long Do Edibles Last: What to Expect and How to Plan ! Hands slicing cannabis gummy on board For most adults, edible effects kick in within 30–90 minutes, peak around 2–4 hours after ingestion, and last roughly 6–12 hours total.
• The Endocannabinoid System: A Concise Science Guide — The Endocannabinoid System: A Concise Science Guide ! Gloved hand pipetting cannabinoid liquid The endocannabinoid system (ECS) is a body-wide signaling network that helps keep your physiology in balance by producing lipid messengers that act at cannabinoid receptors throughout the brain and body.
• Is Weed Legal in Texas in 2026? The Real Answer — Is Weed Legal in Texas in 2026? The Real Answer !
• Cannabis Advertising Laws Every U.S. Marketer Must Know — Cannabis Advertising Laws Every U. S.
• The Indoor Grower's Lighting Blueprint: Why Your Setup Fails (And How to Fix It) — Most indoor growers fail at lighting because they chase generic "18-6 cycles" without understanding *why* light matters. This guide decodes photosynthetically active radiation (PAR), spectrum, and distance—turning vague advice into actionable wattage and fixture specs that stop yield loss before it starts.
• Cannabis and Medication Interactions: What Labels and Clinical Studies Establish — The clearest human evidence concerns prescription cannabidiol, particularly the approved oral cannabidiol formulation covered by its drug label.
• The Amended Federal Hemp Definition: What It Covers and When — As of August 20, 2026, the amended federal definition describes hemp as Cannabis sativa L. , and any part of the plant—including seeds and its derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers—with total tetrahydrocannabinols, including tetrahydrocannabinolic acid, of not more than 0. 3 percent on a dry-weight basis.
• Cannabis and Cardiovascular Health: What the Evidence Shows About Heart Rate, Blood Pressure, and Safe Use — THC temporarily increases heart rate and can affect blood pressure, which matters if you have cardiovascular risk factors or existing heart conditions. Understanding the mechanism, your personal risk profile, and practical harm-reduction strategies lets you make informed choices about cannabis use.
• Cannabis Inventory Recordkeeping: The Obligation Behind the Software — As of August 20, 2026, a cannabis operator’s recordkeeping obligation is broader than maintaining a product count. Records support business transactions, expenses, tax reporting, licensing and operational scrutiny. This position can change after August 20, 2026.
• The Federal Hemp Definition: What Is Enacted and What Has Passed One Chamber — As of August 20, 2026, federal hemp law contains an enacted definition with a 0. 3 percent plant-level threshold, while a separate December 11 provision appears in H. R. 6500, a measure passed by the Senate but not enacted. Those positions are not interchangeable, and the federal position can change after August 20, 2026.
• THCV: The Blood Sugar Cannabinoid Science Is Finally Taking Seriously — THCV, a lesser-known cannabinoid, is gaining serious scientific attention for its role in blood sugar regulation and metabolic health. Recent research reveals how THCV interacts with glucose pathways differently than CBD or THC—and why it may work best as part of a cannabinoid combination rather than alone.
• What Controlled Studies Show About Cannabis Yield and Cannabinoid Content — As of August 20, 2026, controlled studies support a narrower conclusion than the idea that growers can simply dial in potency: changing some growing conditions changed yield, while several tested interventions did not change inflorescence cannabinoid concentration. Results depended on the cultivar, lighting, nutrient treatment, tissue examined, developmental window, and measurement approach.
• Cannabis and Medications: How to Navigate Drug Interactions Safely — Cannabis can interfere with how your body processes common medications by inhibiting cytochrome P450 enzymes. This guide explains which drugs are at highest risk, how to assess your personal interaction potential, and the practical strategies—timing, dosing, monitoring—that let you use cannabis safely alongside your medication regimen.
• Cannabis and Digestion: Why It Affects Your Gut, and How to Use It Intentionally — Cannabis doesn't just trigger the munchies—it actively reshapes how your digestive system functions. Understanding the mechanism behind appetite stimulation, cramping, and potential gut support helps you use cannabis more strategically for digestive health.
• Online Cannabis Ordering: The Rules That Govern the Checkout Itself — As of August 20, 2026, the federal mail, Internet, or telephone order rule provides the starting point for an online checkout: it defines these sales as transactions in which a buyer orders merchandise from a seller by mail, via the Internet, or by telephone, regardless of the payment method or how the order was solicited.
• Automating Cannabis Inventory: What Records Are For, and What AI Does Not Decide — As of August 20, 2026, automation can help an operator create, organize, and review inventory-related records, but it does not decide what compliance requires or replace human and legal review. An automated record is still the licensee’s record. A system’s output is not a regulator’s determination.
• Cannabis and Athletic Recovery: What the Science Actually Says About THC, CBD, and Muscle Repair — Cannabis use among athletes is climbing, but the recovery claims often outpace the evidence. THC may ease inflammation and soreness perception; CBD shows promise for delayed-onset muscle soreness—but neither repairs muscle faster. Here's what athletes actually need to know before adding cannabis to their post-workout routine.
• THCV and Blood Sugar: What One Controlled Trial Shows, and What It Does Not — The human evidence cited here consists of one randomized, double-blind, placebo-controlled pilot trial involving 62 adults with noninsulin-treated type 2 diabetes.
• Medical Cannabis Access by State: What a Registry Requires, With Dated Examples — As of August 20, 2026, Georgia’s medical cannabis route begins with certification by an eligible physician, followed by registration and an active Medical Cannabis card; California illustrates a different framework in which statutes, agency regulations, and local ordinances work together.
• Cannabis Retailers Are Sitting on Gold They Can't Mine: Why Data Strategy Is the New Competitive Edge
• AI Inventory Tracking Is Reshaping Cannabis Supply Chains—Here's Why It Matters — Cannabis operators face a unique inventory challenge: overstock freezes capital in an already capital-constrained industry, while stockouts mean lost sales. AI-powered inventory systems are changing the game by forecasting demand, automating compliance tracking, and cutting waste—helping businesses move faster and smarter.
• How Cannabis Terpenes Rewire Your Brain's Pain Pathways: What New Research Reveals — Fresh neuroscience shows exactly how cannabis terpenes—the aromatic compounds that give strains their distinctive smell—activate the brain's pain-relief pathways. This research explains why two strains with identical THC levels can produce wildly different effects, and why some people respond better to certain terpene profiles than others.
• Cannabinoids and Chemotherapy-Induced Nausea: What the Clinical Evidence Supports — Cannabinoids may have a role in chemotherapy-induced nausea and vomiting (CINV), but the clinical evidence supports them mainly as an adjunct for refractory CINV—not as a replacement for standard antiemetic treatment or as routine first-line therapy.
• Cannabis and Anxiety: What Controlled Dose-Response Studies Show — Controlled studies do not support a universal cannabis dose for anxiety. Instead, they show that THC can produce different acute effects at different study doses, while CBD findings come from separate, limited experiments and should not be treated as evidence of a general treatment dose.
• Cannabis Point of Sale: The Rules a Till Sits Inside — A cannabis point-of-sale system is one part of a retail operation, not the operation’s compliance perimeter. The rules around the till include payment-account security standards, federal tax reporting and recordkeeping, financial-institution due diligence and suspicious-activity reporting, and state and local licensing requirements.
• Selling Cannabis Online: The Obligations That Follow You Onto Any Platform — As of August 20, 2026, selling cannabis online remains a seller-side responsibility: the operator must address order fulfilment, advertising, taxes, records, and state licensing regardless of the software or platform used. This article describes that position as of that date, and the position can change after August 20, 2026.
• Reading a Cannabis Lab Report: What a Measured Number Is—and What It Is Not — A cannabis certificate of analysis describes the sample that was tested. Its reported number is not certainty about every unit made or sold under the same product name.
• How State Cannabis Licensing Frameworks Are Built: Three Dated Examples — A cannabis licensing framework is assembled from several layers: statutes establish the basic legal structure, agency regulations add operational detail, local ordinances control community-level conditions, licence categories define the activities a business may pursue, and registries record people or entities authorized under a specific program.
• THC and CBD: What the Controlled Evidence Actually Separates — A source-grounded review of what controlled human evidence separates about THC and CBD, citing 5 authoritative sources.
• A Cannabinoid Support Nonprofit: What It Says It Does, and What the Clinical Evidence Shows — As of August 20, 2026, the Realm of Caring says it provides cannabinoid information, research, education, advocacy, grants, and free one-on-one support.
• Cannabis Seeds 101: How to Pick Genetics That Match Your Growing Goals — Your seed choice determines everything that follows—genetics, yield potential, flowering time, and success rate. Here's how to pick seeds that match your growing goals, experience level, and environment.
• How to Read a Cannabis or CBD Product Label: What Regulators and Analyses Show — The most important distinction is between what a label claims, what a laboratory analysis found, and what a regulator has approved. For an adult consumer, read the stated cannabinoid and amount as product information to verify—not as proof of FDA approval, medical effectiveness, or exact contents.
• The Terpene Breakthrough: How Cannabis's Aromatic Oils May Relieve Pain Without THC — Emerging research is isolating terpenes—the aromatic oils that give cannabis its distinctive smell—as standalone pain relievers, separate from THC and CBD. This discovery could reshape cannabis medicine and strain selection for patients seeking relief without psychoactive effects.
• Cannabis Genetics and Chemical Profile: What the Genome Evidence Shows — Cannabis genetics can help explain why plants differ in cannabinoid and terpene chemistry: cannabinoid synthase genes are associated with CBD and THC chemotypes, while variation in a diverse terpene synthase gene family contributes to terpene profiles.
• How Texas's Cannabis Ban Became a Corruption Case Study—and What It Means for 2026 — Texas Senate candidate James Talarico has called the state's cannabis restrictions an "insane" form of corruption that benefits big alcohol, big tobacco, and drug cartels while punishing ordinary consumers. The framing—legalization as anti-corruption and pro-consumer—marks a sharp rhetorical shift for reform advocates and signals how the 2026 political cycle will reframe prohibition.
• Shipping Hemp-Derived Products: The Legal Boundary and the Order Rules — As of August 20, 2026, the supplied federal material establishes a product-definition boundary and seller duties for Internet orders, but it does not establish whether a carrier will accept a shipment or whether a payment provider will process it. The federal product definition is scheduled to take effect 365 days after enactment of the act containing it, and the position can change.
• Cannabis and Sleep: Why THC Helps You Fall Asleep but Steals Your Dreams — Cannabis and sleep aren't a simple "it knocks me out" story. THC does help you fall asleep faster, but it also suppresses REM sleep—the dreaming stage tied to memory and mood regulation—which is why heavy users report fewer dreams and why quitting triggers vivid dream rebound.
• High Times at 50: How Cannabis Art and Activism Built a Culture Before Legalization — High Times marked five decades with a monumental colored-pencil mural by artist Liam Wesley Goodman, portraying 36 pivotal figures from cannabis culture. The anniversary is a cultural checkpoint—a reminder that the plant's story predates legal dispensaries by generations, rooted in activism, art, and the people who normalized it.
• Germany's Cannabis Experiment Is Hitting a Wall: What Happens When Legalization Stalls — Germany promised a middle-ground cannabis system—social clubs for adults, medical access for patients—but the rollout is stumbling. Half of club applications are being rejected, and insurers have quietly stopped covering medical flower. The friction reveals how messy legalization actually is.
• Delta-8 and Delta-9 THC: Chemistry, Pharmacology and Legal Status — Delta-8 THC and delta-9 THC are closely related THC isomers with similar pharmacological effects, but the supplied evidence describes delta-8 as generally less potent in clinical studies.
• Automated Licence-Plate Readers: What the Vendor Documents, and What It Does Not Say — As of August 20, 2026, the vendor’s documentation describes a system that can capture, process, store, and provide access to images, video, audio, and licence-plate data. It says authorized law-enforcement searches require a legitimate justification and an audit trail.
• What the Senate Actually Voted On: The Two Roll Calls Behind the Hemp Deadline — As of August 20, 2026, the Senate record shows two separate votes on August 8, 2026: one on a motion to table a numbered amendment and one on passage of H. R. 6500, as amended. The supplied record gives a 90-to-6 tally for the passage vote, but does not provide a numerical tally or separate result for the motion-to-table vote. This position can change after August 20, 2026.
• The VA Psilocybin Trial: What Has Been Registered, and What Has Not Been Measured — The VA’s PIVOT trial has not reported any outcome. There is no reported finding of effectiveness, lack of effectiveness, benefit, harm, or safety from this trial in the record reviewed here. This article describes the trial’s registered position as of August 20, 2026; that position can change after that date.
• The Case for CBD in Athletic Recovery: What 70 Studies Actually Show — Researchers reviewing 70 peer-reviewed studies conclude CBD shows "potentially performance-enhancing properties" for athletes, mainly through anti-inflammatory pathways. The signal is real—but the evidence base has important gaps, and product quality varies wildly.
• Cannabis Marketing Finally Gets a Rulebook: Why Industry Standards Matter for Compliance and Scale — Cannabis marketing operates under a chaotic patchwork of state rules, platform bans, and age-gating requirements that make even routine promotions risky. The Cannabis Media Council is now asking the industry to help write a shared standard—a move that could turn compliance from a guessing game into a buildable spec.
• Linalool: The Lavender Terpene in Cannabis and What the Research Actually Shows — Linalool is the terpene that gives lavender its signature scent—and it's hiding in many cannabis strains too. Early research hints at calming and anti-anxiety effects, but the honest truth is the evidence is still emerging. Here's how to read a terpene panel and what linalool might actually do.
• Minor Cannabinoids: What Is Known About CBG, CBN and CBC — The evidence differs sharply by compound. CBG has been studied in one small, acute, double-blind, placebo-controlled crossover trial involving 34 healthy adults.
• Georgia’s Medical Cannabis Registry: What the State Records Say — This describes Georgia’s Medical Cannabis Patient Registry as of August 20, 2026, and Georgia’s position can change. In Georgia, access begins with certification by an eligible physician, followed by registration and an active Medical Cannabis card; Georgia’s records describe that card as proof of authorization to possess medical cannabis.
• Medical Cannabis Laws Boost Workplace Productivity—Here's What the Data Shows — A new analysis of over 13,000 publicly traded companies finds that states adopting medical cannabis laws see measurable gains in workplace productivity and corporate innovation. The mechanism is straightforward: legal access helps patients manage chronic conditions more effectively, reducing absences and boosting performance.
• What a Cannabis Receipt Shows, and What the Tax Rules Actually Are — As of August 20, 2026, a cannabis receipt should be read as a record of a particular purchase, not as a universal map of cannabis taxation. The available material describes business tax, reporting, calculation, and recordkeeping obligations, but it does not establish a nationwide receipt format or say which tax line items must appear on a consumer’s receipt. The position can change.
• The Federal Hemp Effective Date and the Senate’s One-Month Change — As of August 20, 2026, the federal hemp position described in the supplied record turns on a statutory amendment that takes effect 365 days after the enactment of the underlying Act. A Senate-passed measure would change how that amendment applies until December 11, 2026, but it has passed only one chamber and is not enacted law. The position can change after August 20, 2026.
• New York's Cannabis Microbusiness Farmers' Market Bill Just Leveled the Playing Field for Small Growers — New York Governor Kathy Hochul signed a bill on August 6, 2026, that lets licensed cannabis microbusinesses fully participate in farmers' markets and pop-up events as growers, processors, and retailers. The law is a significant competitive advantage for small operators who lack the capital and marketing budgets of large chain dispensaries.
• Marijuana and Schedule III: The Exact Federal Position as of August 20, 2026 — As of August 20, 2026, the federal record describes two separate actions: a final rule effective April 28, 2026, covering specified FDA-approved drug products and marijuana connected to state medical-marijuana licenses, and a separate proposed transfer of marijuana generally from Schedule I to Schedule III that remained in the rulemaking process in the dated record.
• Massachusetts Voters Will Decide in November Whether to Repeal Legal Cannabis—Here's What's at Stake — Massachusetts voters will decide in November whether to repeal the state's decade-old legal cannabis law. It's the first time any state has voted on repealing an established legal market—and polling suggests repeal faces long odds, but the campaign itself signals that legalization isn't a guaranteed one-way ratchet.
• Rick Ross, Craft Cannabis, and the Dispensary Dilemma — Rick Ross recently told High Times he skips legal dispensaries for underground growers he trusts—a stance that echoes a deeper anxiety among longtime cannabis consumers. The tension between craft legacy producers and regulated retail reveals real questions about quality, control, and what gets lost (or gained) in legalization.
• Cannabis and Physical Activity: What the Evidence Associates, and What It Cannot Show — Bottom line: Human evidence does not establish that cannabis improves exercise performance, fitness, recovery, or aerobic capacity.
• Cannabis and Weight: Why Regular Users Often Weigh Less (Despite the Munchies) — Cannabis is famous for triggering the munchies—yet research consistently finds that regular users weigh less, on average, than non-users. We break down the science behind this counterintuitive finding and what it means for your health.
• Tolerance Breaks, Explained: Does a T-Break Actually Reset Your Tolerance? — If it takes more flower to feel less, your CB1 receptors have adapted. The good news: that change is reversible. Here's what a tolerance break actually resets, how long it takes, and how to get through it.
• Cannabis Awards Are Going Mainstream—But Do They Actually Drive Sales? — Cannabis competitions have exploded from underground events to state-fair staples. But the industry is asking a harder question: does a shiny award actually translate to sales? The answer depends less on the trophy itself than on where shoppers see it.
• 'Super Troopers 3' was written by stoners, on purpose — Stoner comedy grew up, then circled back. Chandrasekhar's framing of the sequel is a quiet snapshot of a culture that stopped whispering.
• Seed to Sale Tracking: A Compliance Guide for Operators — Seed to Sale Tracking: A Compliance Guide for Operators ! Hands tagging cannabis package with RFID Seed-to-sale tracking is the state-mandated, end-to-end digital record of every cannabis lifecycle event, from the moment a seed goes in the ground to the retail transaction at the register.
• Ziggy Marley on Grief, Bob, and His Fear of 'Corporate Weed' — In a new interview tied to his album Brighside, Ziggy Marley names a familiar tension: what a culture loses when it goes mainstream.

View on Cannible →